(Q69054029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

G J Pommier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

F L Garrouste

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

D Bettetini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J M Culouscou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M M Remacle-Bonnet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

225-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3594485%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00205634

29 September 2019

exact match

0 references

cites work

Purification and functional characterization of a low molecular weight immune modulating factor produced by Lewis lung carcinoma

1 reference

12 December 2020

Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma

1 reference

12 December 2020

Modulation of anti-tumour immunity induced by syngeneic mitomycin C-treated murine tumour cells.

1 reference

12 December 2020

Inhibition of lymphocyte growth by spermidine in medium containing fetal bovine serum

1 reference

12 December 2020

Polyamines in Mammalian Tumors Part ii

1 reference

12 December 2020

Polyamines in rapid growth and cancer

1 reference

12 December 2020

Enhancement of production of superoxide anion by human monocytes exposed to products of HT 29 human colonic adenocarcinoma cell line

1 reference

12 December 2020

Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia

1 reference

12 December 2020

The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells

1 reference

12 December 2020

Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations

1 reference

12 December 2020

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity

1 reference

12 December 2020

Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes

1 reference

12 December 2020

Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages

1 reference

12 December 2020

Correlation between immunosuppressive agents from media of human malignant melanoma cell cultures and from human serum

1 reference

12 December 2020

Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma--II. Association with polyamine complexes

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

Tumor induced immunosuppression

1 reference

12 December 2020

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

12 December 2020

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

12 December 2020

Characterization of an inhibitor of cell division released in tumour cell cultures

1 reference

12 December 2020

Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants

1 reference

12 December 2020

Explant culture of human colon

1 reference

12 December 2020

Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen

1 reference

12 December 2020

Inhibition of Lymphocyte Proliferation by Polyamines Requires Ruminant-Plasma Polyamine Oxidase

1 reference

12 December 2020

An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture

1 reference

12 December 2020

Nonspecific suppressive and cytostatic activities mediated by human colonic carcinoma tissue or cultured cell extract

1 reference

12 December 2020

Nonspecific inhibitory activity of soluble human colon carcinoma extracts: tentative mechanism of action

1 reference

12 December 2020

Immunologic reactivity of lymphoid cells in tumors

1 reference

12 December 2020

Soluble suppressor factors elaborated in experimental malignant ascites.

1 reference

12 December 2020

Enhancement of production of superoxide anion by human polymorphonuclear leukocytes exposed to products of the HT-29 human colonic adenocarcinoma cell line

1 reference

12 December 2020

Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation

1 reference

12 December 2020

Immunochemical study of liver metastases of colonic tumors

1 reference

12 December 2020

Immunosuppressive factors from mastocytoma cells cultured in serum-free medium

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

12 December 2020

Murine alveolar macrophage-mediated lymphocyte cytostasis: kinetics and mechanisms

1 reference

12 December 2020

Immunosuppression associated with SJL/J murine lymphoma. II. Characterization of a plasma suppressor factor in tumor-bearing mice

1 reference

12 December 2020

Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

1 reference

12 December 2020